About

The key to your success is here.

ACR Image Metrix™ is your choice imaging CRO that truly understands your research needs. With extensive access to world-renowned experts and an impeccable reputation, ACR Image Metrix offers you the ability to utilize imaging in your Early Phase (I & II) trial, Late Phase drug study as an endpoint or for device software approval studies.

The advantages of working with ACR Image Metrix draw upon a rich history of networks. As the wholly-owned commercial imaging CRO of the American College of Radiology^® (ACR^®), ACR Image Metrix generates revenue that is reinvested into the ACR Clinical Research Center. Our goal is to help you improve the effectiveness of your research project through advantages offered in imaging options. We are currently partnering with over 30 pharmaceutical, biotechnology and medical device manufacturing companies across multiple Phase I-IV trials and registries. In addition, we have the capacity to perform correlative and adaptive trial designs, as well as global coverage conducting studies in Latin America, both eastern and western Europe, India, Asia, Australia, New Zealand, United States and Canada.